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1. Introduction
  Malaria is a parasitic infection caused by Plasmodium 
species, and is one of the oldest and greatest health 
challenges affecting 40% of the world’s population[1]. 
Malaria deaths peaked at 1.82 million in 2004 and fell to 
1.24 million in 2010 (714 000 and 524 000 deaths are children 
that are less than and greater than 5 years, respectively) 
and over 80% total deaths occur in sub-Sahara Africa[2]. The 
disease is a major obstacle to economic advancement of 
many developing and tropical nations predisposing people 
to poverty. Chemotherapy remains a major means of malaria 
control. However, the previously efficacious chloroquine 
(CQ) is failing both as a prophylactic and therapeutic 
Objective:  To investigate the antimalarial potential of kolaviron (KV), a biflavonoid fraction from 
Garcinia kola seeds, against Plasmodium berghei (P. berghei) infection in Swiss albino mice. 
Methods: The study consists of seven groups of ten mice each. Groups 栺, 栻and 栿 were normal 
mice that received corn oil, KV1 and chloroquine (CQ), respectively. Groups 桇, 桋, 桍 and 桏 
were infected mice that received corn oil, CQ, KV1 and KV2, respectively. CQ, KV1 and KV2 
were given at 10-, 100- and 200-mg/kg daily, respectively for three consecutive days. Results: 
Administration of KV1 and KV2 significantly (P<0.05) suppressed P. berghei-infection in the mice 
by 85% and 90%, respectively, while CQ produced 87% suppression relative to untreated infected 
group after the fifth day of treatment. Also, KV2 significantly (P<0.05) increased the mean survival 
time of the infected mice by 175%. The biflavonoid prevented a drastic reduction in PCV from day 
4 of treatment, indicating its efficacy in ameliorating anaemia. Significant (P<0.05) oxidative stress 
assessed by the elevation of serum and hepatic malondialdehydewere observed in untreated P. 
berghei-infected mice. Specifically, serum and hepatic malondialdehyde levels increased by 
93% and 78%, respectively in the untreated infected mice. Furthermore, antioxidant indices, viz; 
superoxide dismutase, catalase, glutathione-s-transferase, gluathione peroxidase and reduced 
gluathione decreased significantly (P<0.05) in the tissues of untreated P. berghei-infected mice. 
KV significantly (P<0.05) ameliorated the P. berghei-induced decrease in antioxidant status of 
the infected mice. Conclusions:  This study shows that kolaviron, especially at 200 mg/kg, has 
high antimalarial activities in P. berghei-infected mice, in addition to its known antioxidant 
properties. 
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antimalarial drug in many endemic countries of Africa, due 
to the emergence of CQ resistant Plasmodium falciparum 
strains with mutant alleles for CQ resistance transporter 
proteins (pfcrtT76) and multidrug resistance glycoprotein-1 
(pfmdr-1Y86)[3,4]. Hence, the diminished potency of CQ in 
many of the endemic countries have paved way for research 
into discovery and/ or development of new antimalarial 
drugs. In the last decade, several fundamental researches 
have been conducted to explore antimalarial activity of 
many plants, including Citrus cinensis, Carica papaya, 
Swertia chirata[5], Bidens pilosa[6], Nigella sativa[7], Piper 
sarmentosum, Tinospora cordifolia[8] and many others[9]. 
  Garcinia kola Heckel (family Guttiferae) is a cultivated large 
forest tree, valued in most parts of West and Central Africa 
for its edible nuts[10]. The seed, known as bitter kola or false 
kola, is commonly chewed and serves as an alternative to 
true kola nuts (Cola nitida and Cola accuminata). Extracts of 
various parts of the plant are used extensively in traditional 
African medicine[11], especially for the preparation of 
remedies for the treatment of laryngitis, cough and liver 
diseases[12]. Chemical investigations of the seeds have shown 
that they contain a complex mixture of phenolic compounds, 
including GB-type biflavonoids, xanthones, benzophenones, 
cycloartenol and triterpenes[13,14]. Kolaviron (KV) (Figure 1) 
is a bifavonoid complex isolated from the seeds of Garcinia 
kola and has been reported to possess neuroprotective, anti-
infammatory, antimicrobial, antioxidant, antigenotoxic and 
hepatoprotective activities in model systems via multiple 
biochemical mechanisms[15-18]. Furthermore, studies by 
Adaramoye et al[19] and, Adaramoye and Medeiros[20] showed 
that KV has anti-atherogenic and vasorelaxant effects in 
animal model and isolated smooth muscle, respectively. 
There is limited information on the effect of this biflavonoid 
on the growth of Plasmodium species in animal model. 
This study was therefore designed to investigate the in vivo 
antimalarial effect of kolaviron in Plasmodium berghei (P. 
berghei)-infected mice. 
Figure 1. Structures of KV and CQ.
2. Materials and methods
2.1. Chemicals 
  Glutathione, Hydrogen peroxide, 5,5’-dithios-bis-2-
nitrobenzoic acid and epinephrine were purchased from 
Sigma Chemical Co., Saint Louis, MO USA. Absolute ethanol, 
trichloroacetic acid and thiobarbituric acid  were purchased 
from British Drug House Chemical Ltd., Poole, UK. Other 
chemicals were of analytical grade and purest quality 
available. 
2.2. Plant material and extraction procedure
  Garcinia kola seeds (Guttiferae heckel) seeds were 
purchased from a local vendor in Ibadan, Nigeria. Kolaviron 
was extracted from the fresh seeds of the Kola (3.5 kg) 
and characterized according to the method of Iwu et al[21]. 
Briefly, powdered dried seeds were extracted with light 
petroleum ether (b.p. 40-60 曟) in a soxhlet extractor for 24 h.
The defatted, dried marc was repacked and then extracted 
with methanol. The extract was concentrated and diluted 
to twice its volume with distilled water and extracted with 
ethyl acetate. The concentrated ethyl acetate fraction gave a 
yellow solid known as kolaviron. The yield of the preparation 
was 6%.
2.3. Animals
  Male adult Swiss albino mice were obtained from the 
animal house of the Institute for Advanced Medical 
Research and Training, College of Medicine, University of 
Ibadan, Nigeria. The animals were housed in well-aerated 
plastic cages, fed with standard mouse cubes (Ladokun 
Feeds, Nigeria, Ltd) and supplied with clean drinking water 
ad libitum. P. berghei used in this study was a donation to 
the laboratory of one of us (OGA) by Malaria Research and 
Reference Reagent Resource Centre (MR4). The parasites 
were maintained in animals by serial passages of blood 
collected from a patent donor mouse to a naive recipient. 
Handling of animals and other protocols conform to the 
guidelines of the National Institutes of Health and Animal 
Ethical Committee of University of Ibadan, Nigeria, for care 
of laboratory animals. 
2.4. Course of infection and antimalarial activity
  The course of infection of P. berghei following 
intraperitoneal inoculation in mice was studied in each 
experimental mouse that received 107 parasitized red blood 
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cells in 0.2 mL inoculum. Thin blood films were prepared 
from the tail vein of infected mice, fixed with methanol and 
stained with 10% Giemsa stain using standard procedure. 
Parasitemia was monitored daily and blood smears were 
read using 暳100 objective of a light microscope. In vivo 
antimalarial activity against P. berghei infection in mice was 
done according to Rane’s test as described by Elufioye and 
Agbedahunsi[22]. The test relies on the ability of a standard 
inoculum of Plasmodium yoelli to kill the recipient mouse 
within 12 days of inoculation. Extension of survival beyond 
12 days is regarded as activity. 
2.5. Study design
  Mice weighing between 18 and 23 g were distributed into 
seven groups of ten animals each. Group 栺: uninfected 
normal mice (positive control), group 栻: uninfected normal 
mice that received KV at a dose of 100 mg/kg (KV1), group 
栿: uninfected normal mice that received CQ, group 桇: 
untreated infected mice (Negative control), group 桋: infected 
mice treated with CQ, group 桍:  infected mice that received 
KV1 and group 桏: infected mice that received KV2 (200 mg/
kg)[23]. CQ and KV were adminstered to infected mice after
72 h of parasite inoculation when the infection was 
established. CQ and KV were dissolved in distilled water and 
corn oil, respectively and given daily for three consecutive 
days (Days 3, 4 and 5 post-infection) to the animals by 
oral gavage. The control animals received equivolume of 
corn oil (vehicle), and CQ was given at dose of 10 mg/kg 
body weight[24]. The levels of parasitemia in the mice were 
monitored daily untill day 10 before half of the animals (n=5) 
were sacrificed. The blood and liver of sacrificed animals 
were obtained for biochemical assay. The remaining five 
mice per group were monitored to obtain survival time. 
2.6. Preparation of samples
  Portion of the whole blood from each animal was collected 
into heparinized bottles, stored at 4 曟 and the red cells 
were assayed for antioxidant parameters. The other portion 
was taken into plain centrifuge tubes and allowed to stand 
for 2 h before centrifugation to obtain serum. The serum 
was used to determine the extent of lipid peroxidation and 
some enzymes markers. Liver was excised after dissection 
of the animals and rinsed in ice-cold 1.15% KCl, dried and 
weighed. The liver samples were homogenized in 4 volumes 
of 50 mM phosphate buffer, pH 7.4 using a Potter Elvehjem 
homogenizer and centrifuged at 10 000 g for 15 minutes to 
obtain post-mitochondrial supernatant fraction (PMF). 
2.7. Biochemical and physiological assays 
2.7.1. Determination of Haematocrit
  The haematocrit or packed cell volume (PCV) was 
determined to predict the effectiveness of the biflavonoid 
in preventing anaemic conditions in malaria[25]. Blood was 
drawn from the tail of the mice in the different groups into 
heparinised capillary tubes. Capillary tubes were filled 
to mark, sealed at one end and spun for ten minutes in a 
micro-haematocrit centrifuge.  The haematocrit of each 
animal was subsequently read with haematocrit reader.
2.7.2. Protein
  Serum and PMF protein levels were determined according 
to the method of Lowry et al[26] using bovine serum albumin 
as standard.
2.7.3. Alanine (ALT) and aspartate aminotransferases (AST)
  The activities of serum ALT and AST were determined by 
the combined methods of Mohun and Cook[27], and Reitman 
and Frankel[28].
2.7.4. Total bilirubin and urea
  Serum total bilirubin and urea levels were assayed by 
the methods of Rutkowski and Debaare[29] and, Talke and 
Schubert[30], respectively. 
2.7.5. Superoxide dismutase (SOD), catalase (CAT) and 
glutathione-S-transferase (GST)
  SOD activity was measured by the nitroblue tetrazolium 
reduction method of McCord and Fridovich[31]. The GST 
activity was determined by the method of Habig et al[32], the 
method is based on the rate of conjugate formation between 
glutathione and 1-chloro-2,4-dinitrobenzene. The CAT 
activity was assayed by measuring the rate of decomposition 
of hydrogen peroxide at 240 nm as described by Aebi[33]. 
2.7.6. Glutathione Peroxidase (GPx), Reduced glutathione 
(GSH) and lipid peroxidation
  The GPx activity was determined according to the method 
of Rotruck et al[34]. Reduced GSH level was assayed by 
measuring the rate of formation of chromophoric product in 
a reaction between 5,5-dithio-bis (2-nitrobenzoic acid) and 
free sulfhydryl groups at 412 nm by the method of Moron et 
al[35]. The extent of lipid peroxidation (LPO) was estimated 
by the method of Walls et al[36]. The method involved the 
reaction between malondialdehyde (MDA) and thiobarbituric 
acid to form a pink precipitate, which was read at 535 nm 
spectrophotometrically. 
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2.8. Statistical analysis
  The results were expressed as mean暲standard deviation 
(SD) of 10 mice per group. Data were analysed using one-way 
analysis of variance (ANOVA) followed by post-hoc Duncan’s 
multiple range test for analysis of biochemical data using 
SPSS (12.0) statistical software. Values were considered 
statistically significant at P<0.05.
3. Results
3.1. Effects of KV and CQ on parasitemia and body weight of 
P. berghei infected mice
  A progressive increase in average percentage parasitaemia 
was observed in P. berghei infected mice, with a maximum 
of 81% average parasitaemia by day 10 (post infection). 
However, the results showed that CQ, KV1 and KV2 were 
able to suppress parasitaemia considerably by day 6 (post 
infection), while KV2 had the highest percentage suppression 
of 92% at day 10 post-infection (Table 1). In addition, KV1 
and KV2 extended the mean survival time of the mice to 15.8 
and 28.1 days, respectively, when compared with CQ (14.6 
days) and untreated infected group (10.2 days) (Table 2). In 
addition, P. berghei infection caused significant (P<0.05) 
decrease in the body weights-gain in the mice relative to 
normal. Treatment with CQ and KV significantly (P<0.05) 
increased the body weight-gain of the infected mice (Table 
2). 
Table 2
Effect of KV and CQ on the mean survival time and body weights in 
normal and P. berghei-infected mice.
Treatment Mean
survival
time (Days)  
 Body weight (g)   Changes in
body weight (g)  Initial  Final
Normal 58.0暲1.4 18.9暲0.9   23.1暲1.8   4.2暲0.7
Normal + KV1 49.7暲0.8 18.3暲1.4 22.7暲0.8         4.4暲0.5
Normal + CQ 45.1暲1.1  18.7暲1.1 22.6暲1.2   3.9暲1.0
Infected only 10.2暲0.5* 19.3暲1.6 17.5暲1.0* -1.8暲0.3*
Infected + CQ 14.6暲0.9*        19.5暲1.0 21.3暲0.8   1.8暲0.1*
Infected + KV1 15.8暲0.7* 19.2暲1.6   23.0暲1.1   3.8暲0.7a
Infected + KV2 28.1暲1.2*,a 18.5暲1.0        22.9暲1.0   4.4暲0.5a
Values are reported as mean暲SD (n=5, 10 for mean survival time and 
body weight, respectively).
* 
Significantly different from normal (P<0.05); a Significantly different 
from infected only (P<0.05).
KV1= Kolaviron at a dose of 100 mg/kg, KV2= Kolaviron at a dose of 
200 mg/kg.
3.2. Effects of KV and CQ on PCV and serum biochemical 
indices of P. berghei infected mice
  The PCV of untreated, infected mice decreased significantly 
(P<0.05) as the infection progressess. However, treatment 
with KV and CQ significantly (P<0.05) ameliorated the P. 
Table 1
Effect of KV and CQ on the levels of parasitemia in normal and P. berghei-infected mice.
Treatment 3 4 5 6 7 10
P% S% P% S% P% S% P% S% P% S% P% S%
Infected only 17.0暲0.1   0.0 23.0暲0.4   0.0 38.0暲0.4   0.0 71.0暲0.8   0.0 78.0暲1.2   0.0 81.0暲0.7   0.0
Infected +CQ 15.0暲0.2 11.7 20.0暲0.6  13.1 24.0暲0.3 36.8 12.0暲0.3a 83.1a 10.0暲0.2a 87.2a 12.0暲0.6a 85.2a
Infected +KV1 17.0暲0.1   0.0 21.0暲0.6  8.7 28.0暲0.5 26.3 19.0暲0.2 73.2a 12.0暲0.3a 84.6a 13.0暲0.2a 84.0a
Infected +KV2 16.0暲0.2   5.9 20.0暲0.6  13.0 23.0暲0.5 39.5 20.0暲0.2 71.8a   8.0暲0.2a 89.7a   6.0暲0.3a 92.6a
Values are reported as mean暲SD (n=10), 
a Significantly different from corresponding values in days 3, 4 and 5 (P<0.05). 
% P= Percentage parasitaemia, % S= Percentage suppression, KV1= Kolaviron at a dose of 100mg/kg, KV2= Kolaviron at a dose of 200mg/kg, 
NOTE: Samples on day 3 were collected before commencement of treatment.
Table 3 
Effect of KV and CQ on the PCV in normal and P. berghei-infected mice.
Treatment/ Days      PCV(%)
3 4 5 6 7 10
Normal  53.4暲2.5             52.8暲1.1   52.5暲1.2 53.2暲2.1  53.5暲1.4  53.7暲1.2
Normal + KV1 51.2暲1.3             51.3暲2.1   52.4暲0.9 51.5暲1.3 52.6暲1.0 52.2暲1.3
Normal + CQ 52.8暲3.9 52.0暲1.8  52.3暲1.4 51.9暲2.2 52.0暲2.0   52.0暲2.0  
Infected only   42.5暲2.3*   43.1暲1.3*   40.2暲1.6*   38.7暲1.3*   37.4暲1.1*   32.1暲0.9*
Infected + CQ   43.0暲1.8*   41.6暲2.1*   43.8暲1.0*   48.2暲1.7* 50.7暲1.0 52.0暲1.1
Infected + KV1   43.7暲1.3*  42.9暲3.6*   45.7暲1.7* 50.4暲2.1 50.2暲1.1 53.5暲2.3
Infected + KV2   44.1暲2.1*  43.8暲3.2*   46.0暲2.0* 51.3暲1.8 52.3暲1.4     52.8暲1.0
Values are given as mean 暲SD (n=10). 
* Significantly different from normal (P<0.05). KV1= Kolaviron at a dose of 100mg/kg, KV2= Kolaviron at a dose of 200 mg/kg, 
NOTE: Samples on day 3 were collected before commencement of treatment.
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berghei-induced decrease in PCV at days 6 and 7 post-
infection, respectively (Table 3). P. berghei infection also 
caused significant (P<0.05) increase in the activity of serum 
alanine aminotransferase (ALT) in the mice. Importantly, the 
serum ALT of untreated, infected mice increased by 107%, 
relative to normal, while treatment with CQ and KV reversed 
the P. berghei-induced alterations in the activity of ALT. 
There were no significant differences (P>0.05) in the levels 
of serum urea, total bilirubin and activity of serum AST of P. 
berghei infected mice when compared to others (Table 4).
 
Table 4
Effect of KV and CQ on serum biochemical indices of P. berghei 
-infected mice.
Treatment AST (IU/L)   ALT (IU/L)      Urea 
(毺mol/L)
 Total bilirubin
Normal 39.0 暲 6.8    29.6 暲 5.9* 11.8 暲 2.1 2.59 暲 0.17
Normal + KV1 38.5 暲 8.0    30.4 暲 7.2* 12.0 暲 1.9 2.83 暲 0.20
Normal + CQ 39.4 暲 6.3     32.8 暲 6.4*   10.6 暲 2.0   3.01 暲 0.28
Infected only 36.7 暲 8.1 61.3 暲 8.1 12.7 暲 2.8   2.76 暲 0.35
Infected + CQ 38.3 暲 7.5    33.0 暲 6.1* 11.0 暲 2.3    2.38 暲 0.31
Infected + KV1 40.2 暲 9.3    34.4 暲 7.4* 13.0 暲 2.1 2.73 暲 0.19 
Infected + KV2 38.9 暲 9.6    32.8 暲 6.8* 10.8 暲 2.6    2.58 暲 0.26 
Values are given as mean 暲SD (n=5). * Significantly different from 
infected only (P<0.05); KV1= Kolaviron at a dose of 100mg/kg, KV2= 
Kolaviron at a dose of 200 mg/kg,
3.3. Effects of KV and CQ on the antioxidant profiles of P. 
berghei infected mice
  A significant (P<0.05) increase in MDA levels (lipid 
peroxidation index) was observed in P. berghei infected 
mice as parasitemia increased. Precisely, serum and hepatic 
MDA levels were increased by 93% and 78%, respectively in 
infected mice when compared to normal. Administration of 
KV alone significantly (P<0.05) decreased the MDA values of 
the untreated, infected mice (Figure 2).  P. berghei infection 
caused a significant (P<0.05) decrease in the levels of red 
cell and hepatic GSH as well as the activities of SOD, CAT, 
GPx and GST of untreated infected mice relative to normal 
(Table 5, Figures 3 and 4). However, treatment with KV alone 
completely attenuated P. berghei-induced decrease in the 
GSH levels (Table 5), while administration of CQ and KV 
significantly (P<0.05) ameliorated the activities of hepatic 
CAT, GST and GPx of the infected mice (Figures 3 and 4).
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Figure 2. Effects of KV and CQ on levels of serum and hepatic LPO in 
P. berghei-infected mice.
* Significantly different from infected only (P<0.05).
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Figure 3. Effects of KV and CQ on activities of hepatic SOD and CAT 
in P. berghei-infected mice.
* Significantly different from infected only (P<0.05).
Table 5
Effect of KV and CQ on enzymic and non-enzymic antioxidant profiles of P. berghei-infected mice.
Treatment  
Red cell
Hepatic GSH   (毺g/g tissue)GSH (毺g/mL) SOD (U/mg protein)    CAT (U/mg protein)    GST (U/mg protein)  GPx (U/mg protein)    
Normal 0.68暲0.04 1.23暲0.15 0.72暲0.05 0.88暲0.06 0.63暲0.05 1.10暲0.15
Normal + KV1 0.61暲0.05 1.12暲0.15 0.68暲0.04 0.91暲0.05 0.66暲0.03 0.96暲0.10
Normal + CQ 0.59暲0.06           1.25暲0.17  0.70暲0.04 0.83暲0.07 0.54暲0.07 0.92暲0.08
Infected only  0.33暲0.04* 0.71暲0.06*  0.48暲0.05*  0.36暲0.04* 0.28暲0.04* 0.63暲0.07*
Infected + CQ 0.38暲0.05*        0.73暲0.04* 0.67暲0.03   0.43暲0.06*  0.31暲0.05* 0.71暲0.05*
Infected + KV1 0.56暲0.03                  0.98暲0.15  0.65暲0.05 0.79暲0.04 0.57暲0.03 0.90暲0.04
Infected + KV2 0.54暲0.06         1.13暲0.11  0.69暲0.04     0.84暲0.06    0.62暲0.06  0.95暲0.07
Values are given as mean暲SD (n=5); * Significantly different from normal (P<0.05); KV1= Kolaviron at a dose of 100 mg/kg, KV2= Kolaviron at a 
dose of 200 mg/kg, 
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Figure 4.  Effects of KV and CQ on activities of GST and GPx in P. 
berghei-infected mice.
* Significantly different from infected only (P<0.05).
4. Discussion
   The spread of resistance in the malaria parasite to safe, 
affordable and commonly available antimalarial drugs 
especially the monotherapeutic drugs such as chloroquine 
and sulfadoxine-pyrimethamine[37], is a major problem in 
malaria chemotherapy especially in resource poor endemic 
areas.  The emergence of resistance to the artemisinins 
which form the backbone of the currently efficacious 
artemisinin-based combination therapy in Cambodia[38] 
and Myanmar[39] underscore the need to discover and 
develop new antimalarial drugs. The present study has not 
only validated the antiplasmodic activity of KV but has 
also demonstrated its inherent antioxidant properties. In 
this study, KV suppressed the growth of the established P. 
bergei parasites by 93%, against 85% obtained in CQ-treated 
group at day 10. This suggests that the antimalarial efficacy 
of KV against P. berghei is better than CQ. The biflavonoid 
did not clear the parasites completely, but it exhibited 
a marked and significant reduction in multiplication of 
parasites during treatment, indicating that KV may have 
a direct action on the parasites. It has been reported 
that several plant constituents, viz; flavonoids, tannins, 
quinonoid, xanthene, polyphenols, and terpenoids possess 
protein-binding and enzyme-inhibiting properties[40,41]. 
The likely mechanism of action of this biflavonoid may be 
the inhibition of key pathogenic enzymes of the parasite 
since KV is known to interfere with enzyme systems[42,43]. 
Anaemia is a consistent feature of Plasmodium infections[44] 
caused by, among other factors, increased lipid peroxidation 
as a consequence of oxidative damage to the membrane 
components of erythrocytes[45]. It was observed that in 
addition to the suppression of parasitemia, KV prevented a 
drastic reduction in PCV values in infected mice showing 
its ability to ameliorate anaemia. The amelioration of the P. 
berghei induced anaemia by KV may be attributable to its 
scavenging effects towards the generated ROS and thereby 
reducing the oxidative attack to which the erythrocytes 
membranes are exposed in the infected mice. The reduction 
in anaemia was consistent with the marked decrease in 
parasite load observed in the course of infection in the 
groups of mice treated with 100- and 200- mg/kg doses 
of the biflavonoid. This may be a subtle evidence of the 
efficacy of the antimalarial effect of KV as red blood cell 
lysis tends to be more severe with sustained parasitemia. 
  The role of oxidative stress as an important clinical and 
biochemical mechanism of the disease pathogenesis is 
increasingly becoming relevant[46,47]. It results from the 
high metabolic rate of the rapidly growing and multiplying 
parasite which produces large quantities of toxic redox 
active by-products. The observed elevation in MDA values 
of infected mice in this study is in concordance with the 
findings of Rodrigues and Gamboa[48] and Okeola et al[7]. 
Increased MDA implies increase in reactive oxygen species 
(ROS) levels, which are cellular renegades, and can wreak 
havoc in biological systems by tissue damage, altering 
biochemical compounds, corroding cell membranes and 
killing out rightly[49]. This claim was further supported by 
decrease in red cell and hepatic activities of SOD, CAT, GPx, 
GST and levels of GSH in the infected mice, which indicate 
that excess ROS probably inactivate these antioxidant 
enzymes. This observation is in line with the findings of 
Ibrahim et al[50], who linked the reduced activities of SOD 
and CAT in P. berghei infection to excessive generation of 
ROS. However, administration of KV increased the activities 
of the antioxidant enzymes. It would appear therefore that 
the biflavonoid kept the levels of ROS low thereby reducing 
the extent of P. berghei-induced lipid peroxidation and/ 
or increase the levels of substrate (GSH) required for 
detoxification by GPx and GST. The in vivo antioxidant 
effects of KV led to the restoration of antioxidant status of 
infected mice and, this would obviously provide greater 
protection for cell membrane components as well as other 
susceptible cellular components and hence significantly 
retarding the P. berghei associated organ pathological 
effects. P. berghei infection has been reported to cause 
hepatomegaly and splenomegaly in the mice model[51] and 
was linked to increased phagocytosis of infected cells by 
macrophages and deposition of malarial pigment as well 
as activation and hyperplasia of the reticulo-endothelial 
system during the disease[52]. In this study, elevated levels of 
serum ALT was observed in infected mice. The ability of KV 
to reverse the serum ALT values in this study, could suggest 
that KV may be protective against P. berghei induced 
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hepatomegaly in the mice.
  In conclusion, kolaviron, a biflavonoid from Garcinia kola 
seeds, elicited potent antimalarial activity in P. berghei 
infected mice.  In addition, kolaviron at the administered 
doses ameliorated the parasite-induced anaemia and body 
weight alterations, possibly through interfering with lipid 
peroxidation process as well as sparing endogenous primary 
antioxidant enzymes reserves.
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